EnteroBiotix logo

EnteroBiotix

EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.

7

Funding Rounds

$90.2m

Money raised

Overview

EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.

Funding

Funding series

Funding Series Analysis

The company EnteroBiotix has raised a total of $90.22m in funding over 7 rounds.

Key Insights:

  • EnteroBiotix April 2024 Series B Funding Round: $29m
  • EnteroBiotix LTD Funding Round, September 2022: $12.99m
  • EnteroBiotix Series A round, September 7, 2022: $21.5m
  • EnteroBiotix September 2021 Series A Funding Round: $21m
  • EnteroBiotix May 2019 Seed Funding Round: $2.5m
  • EnteroBiotix Seed round, May 2019: $2.6m
  • EnteroBiotix June 2017 Seed Funding Round: $630k
EnteroBiotix logo
EnteroBiotix April 2024 Series B Funding Round $29m
EnteroBiotix logo
EnteroBiotix LTD Funding Round, September 2022 $12.99m
EnteroBiotix logo
EnteroBiotix Series A round, September 7, 2022 $21.5m
EnteroBiotix logo
EnteroBiotix September 2021 Series A Funding Round $21m
EnteroBiotix logo
EnteroBiotix May 2019 Seed Funding Round $2.5m
EnteroBiotix logo
EnteroBiotix Seed round, May 2019 $2.6m
EnteroBiotix logo
EnteroBiotix June 2017 Seed Funding Round $630k